<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: During recent years a discussion about cost-effectiveness and importance of follow-up determination of carcinoembryonic antigen (CEA) after curative resection of <z:e sem="disease" ids="C0009402" disease_type="Neoplastic Process" abbrv="CRC">large bowel cancer</z:e> has developed </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: Between 1990 and 1998 follow-up CEA levels of 1,321 patients after curative <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> resection were prospectively collected in cooperation with family physicians, CEA determinations were made with different assays by various laboratories </plain></SENT>
<SENT sid="2" pm="."><plain>The reported findings were adjusted for the different methods used </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: 306 patients developed <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> following curative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> resection (23.2% of <z:hpo ids='HP_0000001'>all</z:hpo> patients) </plain></SENT>
<SENT sid="4" pm="."><plain>Regarding the role of follow-up CEA determination, they were divided into: I. no preoperative CEA determination/insufficient follow-up (N = 47); II. no elevation of CEA with primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, a) elevation with <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> (N = 62), b) no elevation at any time point (N = 53), c) role of CEA not completely elucidated (N = 41); III. elevated CEA levels with primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, a) no increase with <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> (N = 21), b) increase with other symptoms of <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> (N = 45), c) increased levels as early symptom of <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> (N = 37) </plain></SENT>
<SENT sid="5" pm="."><plain>30 patients (9.8% of <z:hpo ids='HP_0000001'>all</z:hpo> patients with <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e>; 2.3% of <z:hpo ids='HP_0000001'>all</z:hpo> patients) with increased CEA levels at the time of <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> underwent surgical resection with curative intention (R0 resection) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Our findings indicate that up to 47% of the patients with <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> and 11% of <z:hpo ids='HP_0000001'>all</z:hpo> patients (N = 144, groups IIa + IIIb + IIIc) could benefit from routine follow-up CEA determinations after curative <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> resection </plain></SENT>
<SENT sid="7" pm="."><plain>Nonetheless, only 2.3% of <z:hpo ids='HP_0000001'>all</z:hpo> patients with elevated CEA levels underwent R0 resection of <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Despite these detection and R0 resectability rates, CEA plays a crucial role in the early detection of <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> and remains an important part of routine patient care after curative resection of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>